Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

In Vitro and in Vivo CYP3A64 Induction and Inhibition Studies in Rhesus Monkeys: A Preclinical Approach for CYP3A-Mediated Drug Interaction Studies

Thomayant Prueksaritanont, Yuhsin Kuo, Cuyue Tang, Chunze Li, Yue Qiu, Bing Lu, Kristie Strong-Basalyga, Karen Richards, Brian Carr and Jiunn H. Lin
Drug Metabolism and Disposition September 2006, 34 (9) 1546-1555; DOI: https://doi.org/10.1124/dmd.106.009878
Thomayant Prueksaritanont
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuhsin Kuo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cuyue Tang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chunze Li
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yue Qiu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bing Lu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristie Strong-Basalyga
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen Richards
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian Carr
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiunn H. Lin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 34 no. 9 1546-1555
DOI 
https://doi.org/10.1124/dmd.106.009878
PubMed 
16782766

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received February 22, 2006
  • Accepted June 14, 2006
  • Published online August 22, 2006.

Article Versions

  • Earlier version (June 16, 2006 - 06:08).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Thomayant Prueksaritanont,
  2. Yuhsin Kuo,
  3. Cuyue Tang,
  4. Chunze Li,
  5. Yue Qiu,
  6. Bing Lu,
  7. Kristie Strong-Basalyga,
  8. Karen Richards,
  9. Brian Carr and
  10. Jiunn H. Lin
  1. Department of Drug Metabolism, Merck Research Laboratories, West Point, Pennsylvania
  1. Address correspondence to:
    Dr. Thomayant Prueksaritanont, Department of Drug Metabolism, WP75-100, Merck Research Laboratories, West Point, PA 19486. E-mail: thomayant_prueksaritanont{at}merck.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 20170175
Sep 20171132
Oct 20171188
Nov 201702713
Dec 20171125
Jan 20180195
Feb 201801811
Mar 201801711
Apr 20182144
May 2018293
Jun 20181102
Jul 2018066
Aug 20180203
Sep 20180141
Oct 20180124
Nov 20180205
Dec 20181415
Jan 20191402
Feb 20191104
Mar 20191956
Apr 20191430
May 20191103
Jun 2019625
Jul 2019412
Aug 2019712
Oct 20191100
Nov 20191310
Dec 20193444
Jan 20201313
Feb 2020522
Mar 2020944
May 2020700
Jun 2020833
Jul 2020610
Aug 2020202
Sep 20201112
Oct 2020711
Nov 2020824
Dec 20202234
Jan 202112113
Feb 20211091
Mar 20211721
Apr 20211151
May 2021630
Jun 20211133
Jul 20211021
Aug 20211285
Sep 2021640
Oct 20211042
Nov 20211111
Dec 20212211
Jan 2022631
Feb 2022221
Mar 2022410
Apr 20221130
May 2022656
Jun 20221421
Jul 202222110
Aug 2022821
Sep 20221131
Oct 20221360
Nov 20221225
Dec 20221210
Jan 20232322
Feb 20231635
Mar 2023321

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 34 (9)
Drug Metabolism and Disposition
Vol. 34, Issue 9
1 Sep 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
In Vitro and in Vivo CYP3A64 Induction and Inhibition Studies in Rhesus Monkeys: A Preclinical Approach for CYP3A-Mediated Drug Interaction Studies
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

In Vitro and in Vivo CYP3A64 Induction and Inhibition Studies in Rhesus Monkeys: A Preclinical Approach for CYP3A-Mediated Drug Interaction Studies

Thomayant Prueksaritanont, Yuhsin Kuo, Cuyue Tang, Chunze Li, Yue Qiu, Bing Lu, Kristie Strong-Basalyga, Karen Richards, Brian Carr and Jiunn H. Lin
Drug Metabolism and Disposition September 1, 2006, 34 (9) 1546-1555; DOI: https://doi.org/10.1124/dmd.106.009878

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

In Vitro and in Vivo CYP3A64 Induction and Inhibition Studies in Rhesus Monkeys: A Preclinical Approach for CYP3A-Mediated Drug Interaction Studies

Thomayant Prueksaritanont, Yuhsin Kuo, Cuyue Tang, Chunze Li, Yue Qiu, Bing Lu, Kristie Strong-Basalyga, Karen Richards, Brian Carr and Jiunn H. Lin
Drug Metabolism and Disposition September 1, 2006, 34 (9) 1546-1555; DOI: https://doi.org/10.1124/dmd.106.009878
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • A PBPK model for CBD in adults and children
  • rs2242480 Regulates the Expression of CYP3A4 and CYP3A5
  • Absorption, Metabolism, and Excretion of Taselisib
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics